User profiles for C. Becerra

Christian Correa Becerra

Consultora e Ingeniería Ciudad Verde Ltda
Verified email at civerde.cl
Cited by 568

The continuum of care: a paradigm for the management of metastatic colorectal cancer

…, NJ Meropol, RK Ramanathan, CHR Becerra… - The …, 2007 - academic.oup.com
… Another example of a potentially useful molecular determinant is the C → T polymorphism
at codon 118 of the ERCC1 gene, which seems to play a role in response to oxaliplatin. The …

[HTML][HTML] Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

…, NR Abu-Rustum, J Trent, DD Thiel, C Becerra… - Annals of …, 2020 - Elsevier
Background Early cancer detection could identify tumors at a time when outcomes are
superior and treatment is less morbid. This prospective case-control sub-study (from …

[HTML][HTML] Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma

…, SA Sastra, EN Dekleva, T Saunders, CP Becerra… - Cancer cell, 2014 - cell.com
Sonic hedgehog (Shh), a soluble ligand overexpressed by neoplastic cells in pancreatic
ductal adenocarcinoma (PDAC), drives formation of a fibroblast-rich desmoplastic stroma. To …

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label …

…, S Myrick, J Faruol, R Siegel, T Larson, C Becerra - The Lancet, 2018 - thelancet.com
Background Patients with advanced gastric or gastro-oesophageal junction cancer that
progresses on chemotherapy have poor outcomes. We compared pembrolizumab with paclitaxel …

[HTML][HTML] Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

…, K Park, JL Lee, TY Kim, S Shin, CR Becerra… - British journal of …, 2020 - nature.com
c Sylamer analysis plot shows a statistically significant enriched miRNA signature for miR-34a
for putative target genes, suggesting specific activity of the miR-34a mimic against its …

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial

…, S Nallapareddy, MS Gordon, C Becerra… - The lancet …, 2012 - thelancet.com
Background Inhibition of MEK stops cell proliferation and induces apoptosis; therefore, this
enzyme is a key anticancer target. Trametinib is a selective, orally administered MEK1/MEK2 …

Small Interfering RNAs Directed against β-Catenin Inhibit the in Vitro and in Vivo Growth of Colon Cancer Cells

UN Verma, RM Surabhi, A Schmaltieg, C Becerra… - Clinical Cancer …, 2003 - AACR
C for 2 min, allowed to come to room temperature over 30 min, and then aliquoted and stored
at −20C… sites respectively inserted upstream of a minimal c-fos promoter. The cells were …

Estimation of canine intestinal parasites in Cordoba (Spain) and their risk to public health

…, S Hernández, E López-Cobos, C Becerra… - Veterinary …, 2007 - Elsevier
The prevalence of gastrointestinal parasites in dogs was studied in the province of Córdoba
(southern Spain), with special attention to those parasites that can be transmitted to man. …

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

…, TP Santisakultarm, U Manor, R Xu, CR Becerra… - Nature, 2019 - nature.com
c–e, Pathological grade of tumour stage (c), histological quantification of cancer and stromal
PSC cell abundance (d), and levels of PCC-produced GM-CSF and PSC-produced CCL11 …

Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer

…, C Iclozan, L Lu, MJ Cotter, C Meyer, CR Becerra… - Clinical cancer …, 2010 - AACR
… Herein, we report the modulatory effects of the triterpenoid C-28 methyl ester of 2-cyano-3,12-dioxooleana-1,9,-dien-28-oic
acid (CDDO-Me; bardoxolone methyl) on MDSCs. In different …